Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1

Class I - Dangerous
💊 Drugs Recalled: December 18, 2025 Imprimis NJOF Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Imprimis NJOF, LLC
Reason for Recall:
Presence of particulate matter - Glass like particles.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
ongoing

Product Information

Full Description:

Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1

Product Codes/Lot Numbers:

Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0249-2026

Related Recalls